x
!

Christmas Opening Times

Merry Christmas from all at Coles Miller. Please find our Christmas opening times here.

BREAST IMPLANT SCARE19th Apr 2012

by on 19th Apr 2012

Contact

Lydia BarnettIn response the UK Medicines and Healthcare products Regulatory Agency (MHRA) decided to recall all silicone gel filled breast implants manufactured by PIP.

Further studies have also revealed that PIP dispensed with using a protective barrier and that the unapproved gel was intended for use in mattresses. It has been confirmed that the gel within the PIP implants differs from that described in their manufacturer's design guide and fails to reach the required level of quality. Although the gel has been found not to be toxic, it can cause inflammatory reactions. Further, these implants are more prone to rupture.

It is recommended that all ladies with PIP implants should be referred for an ultrasound scan and those with actual or suspected ruptures should have the implants removed.

The French Government have expressed concerns over the breast implants leaking and a possible link to cancer and is reported to be considering paying for about 30,000 women with PIP implants to have them removed. French health officials also say that nine cases of cancer have been reported in women who had the implants. However researchers say the cancer and the implants are not necessarily linked. Further, the MHRA says that it has been working with professional bodies to look at the incidences of cancer and says there's no risk.

It is understood that more than 300,000 of these implants have been sold across the world by PIP over the last 12 years and that some 40,000 British women could be affected by the French healthcare warnings.

If you believe that you are affected then we recommend that you seek advice in order to bring a Clinical Negligence claim. Compensation may include damages for additional pain & suffering plus any related expenses, for example the cost remedial medical treatment, lost earnings and care needs. The cost of new implants on a private paying basis; could range from £2,000 to £5,000.





This document is not intended to constitute and should not be used as a substitute for legal advice on any specific matter. No liability for the accuracy of the content of this document, or the consequences of relying on it, is assumed by the author. If you seek further information, please contact Managing Partner Neil Andrews at Coles Miller Solicitors LLP.